Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Song Sun

Showing results (521-530 of 542) with videos related to

Pageof 55
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy responseSai-Lan Liu, Xue-Song Sun, Jin-Jie Yan, et al.
Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.
Cancer Letters|February 22, 2023
Retraction notice to "Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis" [Canc. Lett. 468 (2020) 27-40]Shan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
Cancer Letters|October 12, 2019
RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasisShan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.
European Radiology|January 8, 2021
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control studyBei-Bei Xiao, Qiu-Yan Chen, Xue-Song Sun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
European Journal of Cancer (Oxford, England : 1990)|October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trialShan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.
Developmental Cell|April 18, 2024
Identification of signaling pathways that specify a subset of migrating enteric neural crest cells at the wavefront in mouse embryosBingyan Zhou, Chenzhao Feng, Song Sun, et al.
Med (New York, N.Y.)|March 26, 2025
Early-warning signals and the role of H9N2 in the spillover of avian influenza virusesYan-He Wang, Jin-Jin Chen, Jun Ma, et al.
Pageof 55

Showing results (521-530 of 542) with videos related to

Sort By:
Pageof 55
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy responseSai-Lan Liu, Xue-Song Sun, Jin-Jie Yan, et al.
Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.
Cancer Letters|February 22, 2023
Retraction notice to "Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis" [Canc. Lett. 468 (2020) 27-40]Shan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
Cancer Letters|October 12, 2019
RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasisShan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.
European Radiology|January 8, 2021
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control studyBei-Bei Xiao, Qiu-Yan Chen, Xue-Song Sun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
European Journal of Cancer (Oxford, England : 1990)|October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trialShan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.
Developmental Cell|April 18, 2024
Identification of signaling pathways that specify a subset of migrating enteric neural crest cells at the wavefront in mouse embryosBingyan Zhou, Chenzhao Feng, Song Sun, et al.
Med (New York, N.Y.)|March 26, 2025
Early-warning signals and the role of H9N2 in the spillover of avian influenza virusesYan-He Wang, Jin-Jin Chen, Jun Ma, et al.
Pageof 55